NYSE:BSXMedical Equipment
Boston Scientific (BSX): Evaluating Valuation Following Earnings Beat and Raised 2025 Guidance
Boston Scientific (NYSE:BSX) just delivered a second-quarter earnings report that has caught the attention of market watchers. The company not only beat expectations for adjusted earnings and revenue but also raised its net sales outlook for 2025, signaling growing confidence in its growth trajectory. Investors paying close attention may notice that product momentum in lines like FARAPULSE and WATCHMAN is helping the company weather the recent global recall of its ACURATE TAVR system. This...